ClinConnect ClinConnect Logo
Search / Trial NCT06888882

Dilated Perivascular Spaces in the Dentate Nucleus on MRI in Patients with Hypertensive Angiopathy or Cerebral Amyloid Angiopathy

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Mar 17, 2025

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at changes in the brain called dilated perivascular spaces (DPVS) in patients with two conditions: hypertensive arteriopathy (HA) and cerebral amyloid angiopathy (CAA). Both of these conditions affect the small blood vessels in the brain and can lead to issues like bleeding or damage in the brain. The researchers want to use a specific type of brain scan called a 3T MRI to compare the presence of DPVS in patients with HA and those with CAA, as this has not been studied in detail before.

To participate in this trial, you need to be a patient who has had certain types of brain bleeding related to either CAA or HA and has been treated at the CHU de Nîmes hospital in France between January 2015 and December 2024. As long as you meet these criteria and are willing to take part, you could be eligible. Participants will undergo a brain MRI scan to help researchers understand more about these conditions and how they affect the brain. This study aims to deepen our knowledge, which could eventually lead to better treatments for these common brain diseases.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient registered in the CHU de Nîmes (France) stroke database with lobar intracerebral hemorrhage \[ICH\], subarachnoid hemorrhage or cortical superficial siderosis for CAA or basal ganglion ICH for HA
  • Patient managed at the CHU de Nîmes (France) between 01/1/2015 and 31/12/2024
  • Patient with T2-weighted MRI performed with a 3T magnet
  • Exclusion Criteria:
  • Refusal to participate

About Centre Hospitalier Universitaire De Nīmes

The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.

Locations

Nîmes, Occitanie, France

Patients applied

0 patients applied

Trial Officials

Anissa MEGZARI

Study Director

Centre Hospitalier Universitaire de Nīmes

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported